SHZ · 300326.SZ
Shanghai Kinetic Medical Co., Ltd
CN¥6.37+CN¥0.03 (+0.47%)
Shanghai Kinetic Medical Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 13.1% below the high.
Loading market information…
SHH · 603387.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Getein Biotech, Inc’s quoted price sits in the lower half of its reported 52-week range, 26.01% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Getein Biotech, Inc’s forward annual dividend is CN¥0.30 per share, paid semi-annual. The forward yield is 3.55% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Getein Biotech, Inc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Getein Biotech, Inc. is an enterprise primarily focused on the research, development, manufacturing, and global distribution of in vitro diagnostic (IVD) solutions. Founded in 2002 and based in Nanjing, China, the company offers a comprehensive array of diagnostic products. This includes a variety of diagnostic reagents, advanced analytical instruments, and crucial calibrators. Getein also supplies foundational raw materials for reagents, such as monoclonal and polyclonal antibodies, antigens, antiserum, and microspheres. Its extensive product line caters to diverse medical fields, encompassing diagnostics for cardiac markers, inflammatory conditions, renal function, blood coagulation, thyroid disorders, fertility assessments, diabetes care, and thrombus detection. These offerings broadly serve applications in cardiovascular, inflammatory, diabetes, reproductive, renal, hepatic, and other key health areas.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥6.37+CN¥0.03 (+0.47%)
Shanghai Kinetic Medical Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 13.1% below the high.
CN¥13.44-CN¥0.66 (-4.68%)
Ningbo David Medical Device Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 20.47% below the high.
CN¥17.27-CN¥0.27 (-1.54%)
Zhejiang Gongdong Medical Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.85% below the high.
CN¥38.30-CN¥0.45 (-1.16%)
Nanjing Vishee Medical Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 47.0% below the high.
CN¥16.58-CN¥0.19 (-1.13%)
Hvsen Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.17% below the high.
CN¥14.22+CN¥0.11 (+0.78%)
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.86% below the high.
CN¥5.90+CN¥0.30 (+5.36%)
Beijing Leadman Biochemistry Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.32% below the high.
CN¥10.69+CN¥0.04 (+0.38%)
Well Lead Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.9% below the high.
